KROMEK GROUP PLC — Director's Dealing 2026

Jun 4, 2026

National Storage Mechanism | Additional information

RNS Number : 9134G

Kromek Group PLC

04 June 2026

4 June 2026

Kromek Group plc 

("Kromek", the "Company" or the "Group") 

Grant of Long-Term Incentives

Kromek (AIM: KMK), a global detection company delivering best-in-class solutions for the advanced imaging and CBRN detection markets, announces the grant of performance-based share awards under its Long-Term Incentive Plan (the "LTIP") to Executive Directors of the Company.

The Company has granted a total of 15,566,498 share awards under its LTIP in the form of options over ordinary shares of 1p each in the Company ("Ordinary Shares") that vest subject to the achievement of certain performance criteria (the "LTIP Awards") assessed over the three financial years ending 30 April 2028. The LTIP Awards have a nominal value exercise price of 1p per Ordinary Share. The LTIP Awards have been granted to Directors of the Company as follows:

Director	No. of LTIP Awards
Arnab Basu, CEO	7,640,437
Claire Burgess, CFO	2,458,256
Berry Beumer, COO	5,467,805

The LTIP Awards will vest subject to the Company meeting a minimum relative total shareholder return ("RTSR") equal to the FTSE AIM All-Share Index Average Total Shareholder Return ("TSR") over the performance period. 25% of the LTIP Awards will vest on meeting this minimum threshold performance criteria, with vesting thereafter on a straight-line basis up to meeting a maximum performance target of a RTSR that is 30% greater than the FTSE AIM All-Share Index Average TSR.

Once vested, the LTIP Awards may be exercised at any time until the seventh anniversary of the vest date. The vest date is the last day of the performance period if, and to the extent that, the performance criteria has been met and subsequently ratified by the Board.

Accordingly, as at 3 June 2026, the Company had options and LTIPs outstanding over a total of 76,635,732 Ordinary Shares, representing 11.7% of the Company's issued share capital, and PDMRs/Directors had the following interest in the Company's issued share capital:

Director	No. of Ordinary Shares	Vested Options and LTIPs		Unvested Options and LTIPs
		Options	LTIPs	Options	LTIPs
Arnab Basu	3,198,750	8,912,308	7,500,000	375,000	13,557,332
Claire Burgess	-	-	-	2,500,000	1,229,128
Berry Beumer	230,000	6,984,570	5,696,350	375,000	9,974,542
Rakesh Sharma	1,310,208	59,033	-	-	-
Christopher Wilks	277,941	31,104	-	-	-
Matt Boyle	285,000	-	-	-	-

Enquiries 

Kromek Group plc
Arnab Basu, CEO  Claire Burgess, CFO	+44 (0)1740 626 060
Cavendish Capital Markets Limited (Nominated Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance  Andrew Burdis - ECM Michael Johnson - Sales	+44 (0)20 7220 0500
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury	+44 (0)20 4582 3500

Kromek Group plc 

Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.  

The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.  

In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation and solid-state readout technology, are primarily used to protect critical infrastructure, events, personnel and urban environments from the threat of 'dirty bombs'.  

The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.  

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.  

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Arnab Basu
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kromek Group plc
b)	LEI	213800VLHYXGHEX5VQ48
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Options over ordinary shares of 1 penny each
Identification code	GB00BD7V5D43
b)	Nature of the transaction	Grant of options under Long-Term Incentive Plan
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		1p	7,640,437
d)	Aggregated information -      Aggregated volume -      Price	N/A
e)	Date of the transaction	2 June 2026
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Claire Burgess
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kromek Group plc
b)	LEI	213800VLHYXGHEX5VQ48
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Options over ordinary shares of 1 penny each
Identification code	GB00BD7V5D43
b)	Nature of the transaction	Grant of options under Long-Term Incentive Plan
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		1p	2,458,256
d)	Aggregated information -      Aggregated volume -      Price	N/A
e)	Date of the transaction	2 June 2026
f)	Place of the transaction	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Berry Beumer
2	Reason for the notification
a)	Position/status	Chief Operating Officer and President of the Advanced Imaging Division
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kromek Group plc
b)	LEI	213800VLHYXGHEX5VQ48
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Options over ordinary shares of 1 penny each
Identification code	GB00BD7V5D43
b)	Nature of the transaction	Grant of options under Long-Term Incentive Plan
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		1p	5,467,805
d)	Aggregated information -      Aggregated volume -      Price	N/A
e)	Date of the transaction	2 June 2026
f)	Place of the transaction	Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBIGDLLDGDGLX